Keypoint Intelligence and 42 Technology Partner to Accelerate Innovation in Print and Packaging

Keypoint Intelligence and 42 Technology Partner to Accelerate Innovation in Print and Packaging

FAIRFIELD, N.J. and CAMBRIDGE, United Kingdom, Oct. 21, 2025 /PRNewswire/ -- Keypoint Intelligence, a trusted market research and advisory firm for the print and imaging industry, and 42 Technology (42T), a leading product innovation and engineering...

TDK and Gelion Establish Full Collaboration Agreement

TDK and Gelion Establish Full Collaboration Agreement

To advance Sulfur battery technology anticipated to be transformational for the industry SYDNEY, Oct. 21, 2025 /PRNewswire/ -- Gelion plc (AIM: GELN), the global energy storage innovator, is delighted, further to its announcement on 16 October 2025,...

SK Biopharmaceuticals Launches Joint Venture with Eurofarma for AI-based Epilepsy Management Platform

SK Biopharmaceuticals Launches Joint Venture with Eurofarma for AI-based Epilepsy Management Platform

SK Biopharmaceuticals forms a joint venture, Mentis Care, to develop an integrated epilepsy care ecosystem through AI-driven platform commercialization. SEOUL, South Korea, Oct. 21, 2025 /PRNewswire/ -- SK Biopharmaceuticals, Co., Ltd., a biotech...

A.D.A.M. Innovations and SOPHiA GENETICS partner to advance liquid biopsy testing and companion diagnostics for precision oncology in Japan

A.D.A.M. Innovations and SOPHiA GENETICS partner to advance liquid biopsy testing and companion diagnostics for precision oncology in Japan

ROLLE, Switzerland and TOKYO, Oct. 16, 2025 /PRNewswire/ -- A.D.A.M. Innovations, Japan's leading private genetic testing company, and SOPHiA GENETICS (Nasdaq: SOPH), an AI technology company pioneering data-driven medicine, today announced at ESMO...

IBM and Mission 44 Join Forces to Fast-Track AI Skills

IBM and Mission 44 Join Forces to Fast-Track AI Skills

New multi-year collaboration launches in Austin ahead of the 2025 Formula 1 United States Grand Prix to promote STEM career pathways with local students AUSTIN, Texas, Oct. 16, 2025 /PRNewswire/ -- IBM (NYSE: IBM) today unveiled a new multi-year...

ALR Technologies Completes Definitive Manufacturing Agreement for GluCurve Pet CGM

ALR Technologies Completes Definitive Manufacturing Agreement for GluCurve Pet CGM

SINGAPORE, June 25, 2025 /PRNewswire/ -- ALR Technologies SG Ltd. ("ALRT" or the "Company") (OTCPK: ALRTF), the diabetes management company, announces it has entered into a Definitive Manufacturing Agreement with CGM Medical Technology Shen Zhen...

Elektrobit and global partner to jointly develop EV.OS - an AI-centric automotive platform for software-defined vehicles

Elektrobit and global partner to jointly develop EV.OS - an AI-centric automotive platform for software-defined vehicles

AI-centric, smart automotive platform will accelerate the transition towards software-defined mobility. ERLANGEN, Germany, June 25, 2025 /PRNewswire/ -- Elektrobit today announced the signing of a joint development agreement (JDA) with Hon Hai...

Illumina to acquire SomaLogic, accelerating its proteomics business and advancing the company's multiomics strategy

Illumina to acquire SomaLogic, accelerating its proteomics business and advancing the company's multiomics strategy

Combines highly complementary proteomics expertise with Illumina's industry-leading product innovation and global market reach Positions Illumina to achieve growth in a large, expanding market Illumina and SomaLogic have partnered in proteomics...

HCLTech and AMD forge strategic alliance to develop future-ready solutions across AI, digital and cloud

HCLTech and AMD forge strategic alliance to develop future-ready solutions across AI, digital and cloud

NEW YORK and NOIDA, India, June 24, 2025 /PRNewswire/ -- HCLTech (NSE: HCLTECH.NS) (BSE: HCLTECH.BO), a leading global technology company, and AMD (NASDAQ: AMD), a leader in high-performance and adaptive computing, have announced a strategic...

Paradigm Therapeutics, Inc. Announces an Additional Investment by Eshelman Ventures, LLC to Expedite Global Development and Global Registration of SD-101, A Topical Therapy for Treatment Across the Entire Skin Surface of All Subtypes of Epidermolysis Bull

Paradigm Therapeutics, Inc. Announces an Additional Investment by Eshelman Ventures, LLC to Expedite Global Development and Global Registration of SD-101, A Topical Therapy for Treatment Across the Entire Skin Surface of All Subtypes of Epidermolysis Bull

First Topical Therapy Developed to Treat the Wounds and Lesions on the Entire Skin Surface Across All EB Subtypes Funding to be Used to Accelerate Activities Associated with Increasing Manufacturing Development of SD-101 and Commercial Launch of the...

  • 1
  • ...
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • ...
  • 20
  • menu
    menu